We only use strictly necessary cookies (sign-in & payment) — no tracking. More in our Privacy Policy.
VOW3.DE · GER · Industrie & Produktion
72,56 €
+0.02 (+0.03 %) today
Last 4 completed fiscal years · Amounts in EUR · SBC (stock-based compensation) & dividend per share · Growth YoY (prior year) · EPS as GAAP value (unadjusted; company-reported “adjusted” EPS may differ) · SBC & buyback shares are estimates (SBC shares ≈ expense ÷ current price)
| Fiscal year | Revenue | Net income | EPS (GAAP) | Shares (dil.) | SBC in shares | Buybacks (approx.) | Gross margin | Net margin | FCF / share | SBC / share | Dividend / share |
|---|---|---|---|---|---|---|---|---|---|---|---|
Over half of Australian and New Zealand residents have never been invited to shape decisions in their communities, and those who have largely don't believe it made a difference
PR Newswire · Jul 21, 2026
Anubis Claims Hack of Coca-Cola's Fairlife, Threatens to Release Stolen Data
MT Newswires · Jul 21, 2026
Capital One Financial Q2 Earnings Call Highlights
MarketBeat · Jul 21, 2026
D&D Pharmatech Announces The Lancet Gastroenterology & Hepatology Publication of Phase 2 Data Demonstrating Rapid, Weight-Independent Activity of Zabopegdutide (DD01) in MASLD/MASH
P/E
5.5
EPS (GAAP)
€13.29
FCF / share
-€0.58
Market cap
36.35B EUR
Revenue (TTM)
321.91B EUR
Net margin
2.1 %
Gross margin
15.9 %
Data source: SEC EDGAR / offizielle Geschäftsberichte · Prices may be delayed · Not investment advice
| 2025 |
|---|
| 321.91BYoY -0.8% |
| 6.9BYoY -44.3% |
| €13.29YoY -37.8% |
| 501M |
| — |
| — |
| 15.9 % |
| 2.1 % |
| -€0.58 |
| — |
| €5.26 |
| 2024 | 324.66BYoY +0.7% | 12.39BYoY -30.6% | €21.36YoY -32.8% | 501M | — | — | 18.3 % | 3.8 % | -€0.10 | — | €6.36 |
|---|
| 2023 | 322.28BYoY +15.5% | 17.86BYoY +12.7% | €31.79YoY +7.2% | 501M | — | — | 18.9 % | 5.5 % | €9.39 | — | €9.06 |
|---|
| 2022 | 279.05BYoY +11.5% | 15.85BYoY +2.7% | €29.66YoY +0.2% | 501M | — | — | 18.7 % | 5.7 % | €31.03 | — | €8.76 |
|---|
Business Wire · Jul 21, 2026
Sign in and try FairValue Pro free for 3 days — including the fair value of VOW3.DE and unlimited analyses.
Sign in & try 3 days freeThen €8.99/month · cancel anytime
Want to try first? The Alphabet valuation is free for everyone — no account.